Radient Technologies Inc. is a pharmaceutical company specialized in providing quality medical cannabis solutions for the global healthcare industry. Radient’s story dates back to 2001 when a research scientist aimed to develop a sustainable method to extract important ingredients from plants.
In 2005, the company received the very first supply agreement from a United States-based healthcare company. Radient Technologies Inc. Became a public company in 2014. Since then, its common shares are listed on the Toronto Venture Stock Exchange in Canada under the trading symbol RTI. Additionally, the cannabis company is also listed on the OTC Pink Market in the United States, with its common shares trading under the stock symbol RDDTF.
The Edmonton-based company extracts and processes all the active compounds in cannabis and helps to produce quality cannabinoid solutions, including:
• Cannabis extracts
• Cannabis formulations
• Cannabinoid-based ingredients
• Other products
The proprietary extraction and processing technology known as Microwave Assisting Processing (MAP) of the company enables it to accurately control the temperature and extraction duration. The patented continuous flow downstream process allows the company to instantly control the biomass heat to produce high-quality extracts at industrial scale volumes.
Radient provides white label extracts, derivatives, formulations and product solutions with cannabinoids and terpene to its clients and partners. Radient Technologies Inc operates various facilities:
Edmonton manufacturing facilities
i. Edmonton I – processing capacity of 56,000 kilograms of cannabis annually.
ii. Edmonton II – throughput capacity of over 420,000 kilograms of hemp.
iii. Edmonton III – capacity to process 280,000 kilograms of cannabis per year and 2.8 million kilograms of hemp per annum.
Germany manufacturing facility – capacity to process 280,000 kilograms of cannabis per annum and more than 2.8 million kilograms of hemp per annum.
Research and Development Laboratories
i. A primary laboratory at the main head office
ii. Laboratory II and pilot plant in Lyon (France)
The company strategically works in partnership with Aurora Cannabis Inc. and Natac Solutions to expand and strengthen its cannabis business across the world.
In July 2021, the company signed a letter of intent to acquire PBR Laboratories Inc. the potential acquisition could help the company to improve its business operations and drive up the revenue streams with product margins.